UBS Group AG - PROFOUND MED CORP ownership

PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 46 filers reported holding PROFOUND MED CORP in Q3 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PROFOUND MED CORP
ValueSharesWeighting
Q4 2022$22,499
-6.3%
2,066
-65.2%
0.00%
Q3 2022$24,000
+2300.0%
5,944
+2799.5%
0.00%
Q2 2022$1,000
-93.8%
205
-85.6%
0.00%
Q4 2021$16,000
+166.7%
1,428
+376.0%
0.00%
Q1 2021$6,000
-87.2%
300
-87.0%
0.00%
Q4 2020$47,000
-4.1%
2,300
-17.6%
0.00%
Q3 2020$49,000
+16.7%
2,792
+13.0%
0.00%
Q2 2020$42,000
+23.5%
2,470
-30.3%
0.00%
Q1 2020$34,000
+325.0%
3,545
+406.4%
0.00%
Q4 2019$8,0007000.00%
Other shareholders
PROFOUND MED CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 341,767$7,029,00013.80%
GAGNON SECURITIES LLC 821,196$16,883,0002.69%
Gagnon Advisors, LLC 277,252$5,700,0002.56%
Taylor Wealth Management Partners 166,294$3,419,0001.32%
PCJ Investment Counsel Ltd. 126,930$2,611,0001.22%
EAM Global Investors LLC 172,291$3,542,0000.96%
AWM Investment Company, Inc. 348,939$7,174,0000.91%
PURA VIDA INVESTMENTS, LLC 780,567$16,048,0000.58%
Wealth Management Partners, LLC 20,282$554,0000.43%
Parkman Healthcare Partners LLC 69,049$1,420,0000.36%
View complete list of PROFOUND MED CORP shareholders